Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (002932.SZ)

17,88 +0,06 (+0,34 %) À la clôture : 03:04PM CST

Wuhan Easy Diagnosis Biomedicine Co.,Ltd.

East Lake Hi-Tech Development Zone
No.388, Gaoxin 2nd Road
Wuhan 430074
China
86 27 6552 3649
https://www.mdeasydiagnosis.com

Secteur(s): Healthcare
Secteur d’activité: Medical Devices
Employés à temps plein: 1 547

Description

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, manufacture, and sale of in-vitro diagnostic products China and internationally. Its products portfolio includes molecular diagnostic products, such as PCR system, nucleic acid extraction and purification instrument, and sample release reagent; blood gas analyzer; immuno diagnosis, including chemiluminescence immunoassay, fluorescence immunity, and immunoquantitative analyzer; and automatic coagulation analyzer. The company also provides emergency and critical illness information solutions, including software, hardware, and certification consulting services; and third-party medical inspection services. It offers products in the areas of cardiovascular and cerebrovascular diseases, infectious diseases, kidney diseases, diabetes, infectious diseases, prenatal and postnatal care, health examination, thyroid, hormones, blood gas, coagulation, drug metabolism, pathogen detection, etc. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. was founded in 2008 and is based in Wuhan, China.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Wuhan Easy Diagnosis Biomedicine Co.,Ltd. en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.